Filtered By:
Specialty: Pharmaceuticals
This page shows you your search results in order of date. This is page number 18.
Order by Relevance | Date
Total 6905 results found since Jan 2013.
COVID Shot After SARS-CoV-2 Recovery in Pregnancy Ups Antibodies in Infants
WEDNESDAY, Oct. 19, 2022 -- For women with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in pregnancy, vaccination after recovery is associated with increased odds of detectable immunoglobulin (Ig)G in infants, according to a study...
Source: Drugs.com - Pharma News - October 19, 2022 Category: Pharmaceuticals Source Type: news
Europe ’s Covid Wave Suggests U.S. Outbreak Looms Around The Corner
Though cases, hospitalizations and deaths are down across the U.S., mutated omicron variants are gaining ground and high levels of coronavirus have been found in wastewater.
Source: Forbes.com Healthcare News - October 18, 2022 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news
New Lab-Made Covid-19 Coronavirus At Boston University Raises Questions
A preprint describes how a research team created a new hybrid version of the SARS-CoV-2 virus that killed 80% of the mice that it had infected. But is this being misinterpreted?
Source: Forbes.com Healthcare News - October 18, 2022 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science Coronavirus business pharma Source Type: news
Roche’s sales of Covid drugs fall by $1bn
Swiss pharma group says demand for coronavirus tests dropped as severity of virus ebbed
Source: FT.com - Drugs and Healthcare - October 18, 2022 Category: Pharmaceuticals Source Type: news
Roche says Covid drug sales fall $1bn
Swiss pharma group says demand for coronavirus tests dropped as severity of virus ebbed
Source: FT.com - Drugs and Healthcare - October 18, 2022 Category: Pharmaceuticals Source Type: news
Experts Are Predicting A Bad Flu Season. Here ’s Why They Might Be Wrong
The Covid-19 pandemic has kept people apart for much of the past two flu seasons. But the bounce back doesn't have to be dramatic.
Source: Forbes.com Healthcare News - October 17, 2022 Category: Pharmaceuticals Authors: John Drake, Contributor Tags: Science /science Innovation /innovation Healthcare /healthcare Coronavirus Editors' Pick editors-pick Source Type: news
Vaccine makers face revenue slump as demand falls for Covid jabs
Pharmaceutical companies hunt for new revenue streams as coronavirus becomes endemic
Source: FT.com - Drugs and Healthcare - October 16, 2022 Category: Pharmaceuticals Source Type: news
When Will Novavax Vaccines Be FDA Authorized As Covid-19 Boosters?
It ’s been nearly two months since Novavax submitted a emergency use authorization (EUA) application to the U.S. Food and Drug Administration (FDA) for Nuvaxovid to be used as a booster.
Source: Forbes.com Healthcare News - October 13, 2022 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science Coronavirus business pharma Source Type: news
You Won ’t Pay For Medicare Vaccines In 2023
For you, a vaccination is a vaccination; it protects you against something. But, under Medicare, all vaccines are not equal and that means you probably paid more for some than for others.
Source: Forbes.com Healthcare News - October 13, 2022 Category: Pharmaceuticals Authors: Diane Omdahl, Contributor Tags: Retirement /retirement Money /money Innovation /innovation Healthcare /healthcare Coronavirus Source Type: news
Protecting against influenza: A conversation with David Ross, Vice President, Commercial Operations, North America, CSL Seqirus
Our industry is at the forefront of fighting the annual influenza virus. I recently had the chance to connect with David Ross, Vice President, Commercial Operations, North America, CSL Seqirus about how the industry is working to fight the annual flu and what lessons learned during COVID-19 are allowing us to better respond to influenza.
Source: The Catalyst - October 13, 2022 Category: Pharmaceuticals Authors: Mike Ybarra Tags: PhRMA Member Company Vaccines Infectious Diseases Coronavirus Source Type: news
InnovationRx: Declining VC Investment In Digital Health; Plus: Long Covid ’s Impact
InnovationRx is your weekly digest of healthcare news. Sign up!
Source: Forbes.com Healthcare News - October 12, 2022 Category: Pharmaceuticals Authors: Alex Knapp, Forbes Staff Tags: Innovation /innovation Healthcare /healthcare Venture Capital /venture-capital Coronavirus Editors' Pick editors-pick Source Type: news
CDC Recommends Omicron-Specific Covid Boosters For Kids 5 And Up
Uptake of the retooled coronavirus vaccine among Americans 12 years and older has lagged.
Source: Forbes.com Healthcare News - October 12, 2022 Category: Pharmaceuticals Authors: Madeline Halpert, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news
Here ’s Why Exercising Is Tougher After Covid
Researchers said those with long Covid could be less able to exercise, suggesting that people swimming laps may have to switch to low-impact aerobics and doubles tennis players may have to switch to playing golf using a cart.
Source: Forbes.com Healthcare News - October 12, 2022 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Science /science Healthcare /healthcare Lifestyle /lifestyle Breaking breaking-news Coronavirus Source Type: news
Covid Accelerated Healthcare ’s Digital Transformation—Here’s What’s Next
Dr. William Winkenwerder, a former healthcare CEO who also previously served as Assistant Secretary of Defense for Health Affairs, explains how the Covid pandemic accelerated digital transformations in healthcare and what happens next.
Source: Forbes.com Healthcare News - October 12, 2022 Category: Pharmaceuticals Authors: William Winkenwerder, MD, Contributor Tags: Healthcare /healthcare Innovation /innovation Coronavirus Editors' Pick editors-pick Source Type: news
Risk for Type 1 Diabetes in Children May Rise After COVID-19
TUESDAY, Oct. 11, 2022 -- Risk for a new diagnosis of type 1 diabetes (T1D) may persist for up to six months following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children, according to a research letter published...
Source: Drugs.com - Pharma News - October 11, 2022 Category: Pharmaceuticals Source Type: news
